Kane Biotech (KNE) Stock Price Prediction from 2024 to 2045 (Complete Information)

Kane Biotech is a Canadian company involved in the biotechnology sector, particularly in the research of biofilms. To give a context, biofilms are layers developed by bacteria and fungi that hinder the efficiency of antibiotics. To disrupt this challenge regarding biofilm, Kane Biotech was set up in Winnipeg in 2001. As of date, the company has 67 products in the market that are either patented or waiting to be patented.

Other than biofilm-related products, the company also produces various other products, such as StrixNB and Bluestem – oral care products for animals, Aledex – which reduces the risk of infections, etc. In this article, we’ll delve into the intricacies of Kane Biotech (KNE) Stock Price Prediction from 2024 – 2045.

Kane Biotech (KNE) Stock Price Prediction 2024 – 2045

Kane Biotech (KNE) Stock Price Prediction 2024

Kane Biotech (KNE) has already outperformed the previous year in terms of the growth in the stock price. The stock has been on a sustainable uptrend from January 2014. In every month from June to September, the stock price started from 0.150 CAD.

Kane Biotech (KNE) Stock Price Prediction 2025

The average price of the stock of Kane Biotech (KNE) for 2025 will be CAD 0.171, with a high forecast of CAD 0.181, and a lower forecast of CAD 0.162.

Suggested: Moon River Moly (MOO) Stock Price Prediction from 2024 to 2045 (Complete Information)

Kane Biotech (KNE) Stock Price Prediction 2026

The average price of the stock of Kane Biotech (KNE) for 2026 will be CAD 0.193, with a high forecast of CAD 0.204, and a lower forecast of CAD 0.183.

Kane Biotech (KNE) Stock Price Prediction 2027

The average price of the stock of Kane Biotech (KNE) for 2027 will be CAD 0.218, with a high forecast of CAD 0.231, and a lower forecast of CAD 0.206.

Kane Biotech (KNE) Stock Price Prediction 2028

The average price of the stock of Kane Biotech (KNE) for 2028 will be CAD 0.247, with a high forecast of CAD 0.261, and a lower forecast of CAD 0.233.

Kane Biotech (KNE) Stock Price Prediction 2029

The average price of the stock of Kane Biotech (KNE) for 2029 will be CAD 0.279, with a high forecast of CAD 0.295, and a lower forecast of CAD 0.264.

Kane Biotech (KNE) Stock Price Prediction 2030

The average price of the stock of Kane Biotech (KNE) for 2030 will be CAD 0.315, with a high forecast of CAD 0.333, and a lower forecast of CAD 0.298.

Kane Biotech (KNE) Stock Price Prediction 2035

The average price of the stock of Kane Biotech (KNE) for 2035 will be CAD 0.581, with a high forecast of CAD 0.614, and a lower forecast of CAD 0.549.

Kane Biotech (KNE) Stock Price Prediction 2040

The average price of the stock of Kane Biotech (KNE) for 2040 will be CAD 1.070, with a high forecast of CAD 1.131, and a lower forecast of CAD 1.011.

Kane Biotech (KNE) Stock Price Prediction 2045

The average price of the stock of Kane Biotech (KNE) for 2045 will be CAD 1.971, with a high forecast of CAD 2.083, and a lower forecast of CAD 1.863.

Kane Biotech (KNE) Stock – Historical Price

Kane Biotech (KNE) Stock Price 2014

As the morning broke out on the first trading day of 2014, Kane Biotech’s (KNE) stock started trading at 0.450 CAD. Till July 2014, the stock price of Kane Biotech stayed at the same level but from August, the price began to move downwards. It reached 0.175 CAD in October and stayed at that price range till December before it closed at 0.175 CAD in December.

Kane Biotech (KNE) Stock Price 2015

After the stock moved in a sideways trend in June 2015, it moved by 28.57% to close at 0.225 CAD in January. Then again till October 2015, it moved in a sideways trend. In November, the stock touched the high of 0.375 CAD and at the end of the month, it moved up by 18.18% from its last month’s closing price. In December 2015, the stock closed at 0.250 CAD.

Kane Biotech (KNE) Stock Price 2016

The stocks of Kane Biotech (KNE) crashed constantly throughout the year 2016. After the 1st phase of decline in the share price in March and April 2016, the stock began to decline in July 2016. After July, the stock price stayed between the range of 0.150 and 0.100 and till December 2016, the price was almost in that range with the closing price benign 0.125 CAD.

Kane Biotech (KNE) Stock Price 2017

In 2017, the stock price of Kane Biotech (KNE) began moving upwards in July 2017; although there was a spark in the stock price in March 2017, Kane Biotech (KNE) failed to capitalize on the momentum. However, after October 2017, the price of the stock began to decline and reached 0.095 CAD at the end of 2017.

Kane Biotech (KNE) Stock Price 2018

The price of the stocks of Kane Biotech (KNE) went down further in 2018 as the stock started a downtrend in May that was active till July 2018. The opening price of the stock in January 2018 was 0.100 CAD and within July 2018, TSXV: KNE reached the value of 0.060 CAD. The ending price of KNE by the end of 2018 was 0.070 CAD.

Kane Biotech (KNE) Stock Price 2019

Kane Biotech (KNE) finally showed the long-expected uptrend in 2019. Although, before the upward trend began in April 2019, there was an upward and downward fluctuation in the stock between January to March 2019. In May 2019, the price of the stock grew 31.25%. From April 2019 to August 2019, the price of the shares of Kane Biotech rose continuously before it took a sideways trend and closed at 0.140 CAD in 2019.

Kane Biotech (KNE) Stock Price 2020

There was strong downward growth (from February to April 2020) as well as a step-by-step rise in stock price (from May to July 2020) as well as strong downtrend – from August to December 2020 (closing price 0.140 CAD).

Kane Biotech (KNE) Stock Price 2021

Kane Biotech achieved great upward momentum in March and April 2021 as the stock price got up by 22.22% and 30.30% in two consecutive months. The stock price then mainly faced downward trajectory till the end of the year before closing at 0.155 CAD.

Kane Biotech (KNE) Stock Price 2022 & 2023

The share price of TSXV: KNE continued to fall till July 2022; but again from December 2022 to March 2023, the price rose continuously. The respective closing prices for both the years were 0.090 CAD and 0.080 CAD.

Kane Biotech (KNE) Stock – Technical Analysis

Chart and trend analysis:

After the huge fall in the stock price in 2023, the stock has shown outstanding growth in the first six months of 2024 and a sideways trend in the last three months of the year.

Support and resistance analysis:

The current support of these stocks is set at 0.120 CAD – at this price point the stock had previously taken support in March 2021, June 2020, December 2019 and quite a few times before that; the resistance is said around the level of 0.170 CAD.

Kane Biotech (KNE) Stock – Fundamental Analysis

Company financial overview:

Kane Biotech (KNE) Currently possesses a market cap of 17.23 million Canadian dollars; the current debt of the companies stands at 9.21 million CAD.

Company performance overview:

The company was going alright till 2021 – The revenue was above CAD 1M back then, although the net income along with net margin was declining year-on-year. But, in 2022 and 2023 the revenue of the stock fell about 90% to 156K CAD in 2022 and 148.98K CAD in 2023. The net margin of TSXV: KNE went as low as 3379.05% in 2023.

Disclaimer

The stock price predictions shared are for informational purposes only and do not constitute financial advice. The author and blog disclaim any responsibility for financial losses. Always seek advice from a professional before making any investment decisions.

FAQ

Hilda J. Condit

 

Welcome to PredictTorontoStocks! I’m Hilda J. Condit, a seasoned finance professional with a passion for the stock market and a deep-rooted connection to the Toronto Stock Exchange (TSX). With a Bachelor’s degree in Finance and specialized training from CSI Global Education’s Canadian Securities Course (CSC), I bring years of experience and expertise to the world of investment.

Over the years, I have had the privilege of working closely with the TSX, gaining valuable insights and building strong relationships with a diverse range of clients across Canada. My career has been dedicated to providing tailored investment advice and helping individuals and institutions navigate the complexities of the stock market.

In launching PredictTorontoStocks, my goal is to share my knowledge and offer precise stock price predictions to empower investors in making informed decisions. Drawing on my extensive experience and analytical skills, I am committed to delivering accurate forecasts and valuable insights that can help you achieve your investment goals.

Thank you for joining me on this journey. I look forward to contributing to your success in the dynamic world of Toronto stocks.